CNT-vectored delivery of mrna for HIV-vaccines
Ended Definitive Contract Awarded Last action
- Contract number
- 75N93019C00034
- Awardee
-
Luna Labs USA LLC UEI M6JVSYRQRYM9 Part of Luna Innovations Incorporated
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,999,997
Award facts
- Opportunity
-
- NIHAI20171 Solicitation number
- CNT-Vectored Delivery of mRNA for HIV-Vaccines Award Notice · Posted Aug 15, 2019
- Contract value 100% obligated
- $1,999,997.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 3 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Roanoke, VA 24011, USA
- Research
- SBIR Program Phase II Action
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Novation Agreement | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $1,999,997 |
About this award
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Luna Labs USA LLC, a subsidiary of Luna Innovations Incorporated, for the development of a platform for the delivery of mRNA-based HIV vaccines.
The $1,999,997.00 Firm-Fixed-Price contract involves collaborating with New York University (NYU) to evaluate the immunogenicity of novel HIV vaccine immunogens. NYU will produce and characterize the proteins, which will then be co-delivered with the mRNA constructs formulated by Luna Labs using their carbon nanotube (CNT) delivery platform. The goal is to down-select the best performing CNT-mRNA formulation for further testing in rabbit studies.
This contract is part of NIAID's efforts to support the development of innovative HIV vaccine technologies through the SBIR program, which provides funding to small businesses for the research and development of promising technologies.
Quick answers
Who was awarded contract 75N93019C00034?
75N93019C00034 was awarded to Luna Labs USA LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 15, 2019.
How much is contract 75N93019C00034 worth?
The government has obligated $1,999,997 on 75N93019C00034.
Was contract 75N93019C00034 competed?
The extent of competition for 75N93019C00034 was full and open competition after exclusion of sources. The government received 3 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award